Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114195687A discloses a novel Pd-catalyzed synthesis of beta-chloro tetra-substituted alkenyl sulfones, offering high selectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113717038A reveals a green nickel/ketone dual-catalysis method for diaryl ether synthesis, offering cost reduction and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN105801459B reveals a one-pot synthesis method offering high purity and safety advantages for fine chemical intermediates manufacturing and supply chain reliability.
Patent CN117964497A reveals a scalable synthesis route for 3,3-difluoro cyclopentylamine hydrochloride, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101270112A details a polymeric Schiff base-metal complex for high-ee cyclic carbonates, offering superior recyclability and cost efficiency for pharma intermediates.
Patent CN110003089A details high-yield carbazole synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN119930443A details a visible light photocatalytic method for trifluoromethylation. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114835749B details a mild Grignard-based route for DuPhos and BPE ligands, eliminating hazardous P-H intermediates for safer large-scale manufacturing.
Patent CN106279274B enables efficient beta-carbonyl phosphonate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel salt-based purification method for Rebamipide achieving >99.8% purity. Reduces impurities significantly using simple solvents. Ideal for pharmaceutical manufacturing.
Patent CN118666669A reveals efficient asymmetric synthesis for sitafloxacin intermediates. Achieve high purity and scalable production with reduced operational complexity.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN102627684A reveals chromium-free oxidation. Enhances supply chain reliability and reduces environmental waste for pharmaceutical intermediates.
Patent CN108129357B details a novel one-pot method for producing high-purity anamorelin intermediates, offering significant safety and cost advantages for pharmaceutical supply chains.
Patent CN115838330B reveals a visible-light method for dicarboxylic acids using CO2. This breakthrough offers cost reduction and supply chain reliability for fine chemical manufacturing.
Novel taurine-catalyzed synthesis offers green efficiency. Reliable supply chain for pharmaceutical intermediates with reduced environmental impact and cost.
Patent CN115369430A reveals a green electrochemical route for C-3 aminomethylation. Achieves high yields without external oxidants, offering cost-effective manufacturing for pharma intermediates.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Discover advanced benzomorpholone derivatives for oncology. Our patented synthesis offers cost-effective, scalable manufacturing for high-purity BET inhibitor intermediates.
Patent CN113735770B details a novel Rh-catalyzed route to 1-aminoisoquinolines using vinylene carbonate, offering safer reagents and improved atom economy for industrial API manufacturing.